Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy. [electronic resource]
Producer: 20121015Description: 375-80 p. digitalISSN:- 1537-453X
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Brain Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Bridged-Ring Compounds -- administration & dosage
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Taxoids -- administration & dosage
- Treatment Failure
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.